Replies to post #12401 on Naz News, Gappers and FLE's

[mcmike]

TIII t3 xover buy on 10tick

[mcmike]

Scanhits for 111605

3 WHITE SOLDIERS: BCON VISG NITE SLAB
BPA NMTI MTXX: none of Friday's group were green today

oversold bouncers: none

resumption scan: none
ABTL hot hot real hot!

bluesky potential: LMIA CLZR PETS CPTS CCK BLKB LRCX IMGC AAUK DADE

bullish morning star: none

engulfing pattern: MNG

lowpriced flyers (by vol surge today): PTN TESOF PRLS MCZ VISG EMKR CCK BCON DHB

dragonfly doji: MAG CXN

inverted hammer (end downtrend signal): SNTO PLLL ADSX MU PZE JADE

squeeze potential: RUN SGRP BLD

strength stocks: IMGC ING FAST

tweezer bottoms: CCK ESLR PD RBAK RADN ARTG

[mcmike]

SYNC being acquired by NOK

[iconoclassic]

ENMD, 2.28, EntreMed announces Pharmacokinetic goals achieved in two clinical trials (ENMD) 2.40 +0.14:Co announces interim results for two Phase Ib studies for its lead clinical-stage drug candidate, Panzem NCD, in patients with advanced cancer. Results from both dose-escalation studies concluded that the pharmacokinetic profile of Panzem NCD met the study objective. Specifically, a dose and schedule of administration was determined that provided constant exposure of 2-methoxyestradiol allowing the selection of a Phase II dose. Results from the University of Wisconsin have determined a maximum tolerated dose with fatigue as the dose limiting toxicity.

[mcmike]

CYPB entered on chart pattern & volume at 5.76